<?xml version="1.0" encoding="utf-8"?>
<export-example>
  <doc>
    <id>2265</id>
    <completedYear/>
    <publishedYear>2021</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst>230</pageFirst>
    <pageLast>243</pageLast>
    <pageNumber>14</pageNumber>
    <edition/>
    <issue>2021,2</issue>
    <volume>195</volume>
    <type>article</type>
    <publisherName>Wiley</publisherName>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2021-08-03</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>--</thesisDateAccepted>
    <title language="eng">Lenalidomide and Dexamethasone in Relapsed/Refractory Immunoglobulin Light Chain (AL) Amyloidosis: Results from a Large Cohort of Patients with Long Follow-Up</title>
    <parentTitle language="deu">British Journal of Haematology</parentTitle>
    <identifier type="doi">10.1111/bjh.17685</identifier>
    <identifier type="issn">00071048</identifier>
    <enrichment key="OpenAccess">ja</enrichment>
    <enrichment key="opus.source">publish</enrichment>
    <enrichment key="frontdoor_url">https://opus4.kobv.de/opus4-hs-augsburg/2265</enrichment>
    <enrichment key="BegutachtungStatus">peer-reviewed</enrichment>
    <enrichment key="opus.doi.autoCreate">false</enrichment>
    <enrichment key="opus.urn.autoCreate">false</enrichment>
    <licence>Creative Commons - CC BY-NC - Namensnennung - Nicht kommerziell 4.0 International</licence>
    <author>Marco Basset</author>
    <author>Christoph R. Kimmich</author>
    <author>Nicholas Schreck</author>
    <author>Julia Krzykalla</author>
    <author>Tobias Dittrich</author>
    <author>Kaya Veelken</author>
    <author>Hartmut Goldschmidt</author>
    <author>Anja Seckinger</author>
    <author>Dirk Hose</author>
    <author>Anna Jauch</author>
    <author>Carsten Müller-Tidow</author>
    <author>Axel Benner</author>
    <author>Ute Hegenbart</author>
    <author>Stefan O. Schönland</author>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>AL amyloidosis</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>biomarkers</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>gain 1q21</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>lenalidomide</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>prognosis</value>
    </subject>
    <collection role="ddc" number="61">Medizin und Gesundheit</collection>
    <collection role="institutes" number="">Fakultät für angewandte Geistes- und Naturwissenschaften</collection>
    <collection role="DFG-Fachsystematik" number="205-02">Public Health, medizinische Versorgungsforschung, Sozialmedizin</collection>
    <collection role="persons" number="schreck">Schreck, Nicholas (Prof. Dr. rer. nat)</collection>
  </doc>
</export-example>
